The California Institute for Regenerative Medicine is running out of money — but it could soon get a second wind. Advocates for stem-cell research in California are pushing ahead with a plan to save the struggling state-funded California Institute for Regenerative...

The Context: Fatty liver diseases such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic stereohepatitis (NASH), and Wolman disease are especially difficult to study and treat due to the lack of effective disease models that recapitulate their...

IMAGE: Baboons at the Southwest National Primate Research Center. Credit: Kathy West Studios Already approved FDA drug could impact brain cell function Texas Biomedical Research Institute San Antonio, Texas (June 17, 2019) - The William and Ella Owens Medical Research...

ISSCR News - 5 June, 2019 - The International Society for Stem Cell Research (ISSCR), the largest professional organization of stem cell researchers from around the world, opposes the new U.S. Health and Human Services policy to eliminate federal funding for fetal...

FDA Press Release: June 04, 2019 - U.S. District Judge Ursula Ungaro of the Southern District of Florida granted the government’s motion for summary judgment against US Stem Cell Clinic LLC, of Weston, Florida, and US Stem Cell Inc., of Sunrise, Florida, and their...

DURHAM, N.C. (PRWEB)May 30, 2019 - A study released today in STEM CELLS Translational Medicine is the first to demonstrate an efficient delivery system for the sustained release of human placental stem cell (HPSC)-derived conditioned medium (CM) to treat acute kidney...

WINSTON-SALEM, NC – The sixth annual Regenerative Medicine Essentials Course will be held June 10 - 14 in downtown Winston-Salem. The course is made possible through the collaborative partnership between the Regenerative Medicine Foundation (RMF) and the Wake Forest...

One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025, according to Bank of America analysts. The analysts say companies such as Illumina and...

Under a draft proposal, patients would be able to buy some therapies without regulatory approval. By: David Cyranoski Select elite hospitals in China could soon be able to sell experimental therapies that engineer a patient’s own cells to treat diseases such as cancer...

Dr. Anthony Atala in the Regenerative medicine laboratories, Wake Forest Institute for Regenerative Medicine (WFIRM). by Vanesa Listek | 17 hours ago | 3D Printing, Bioprinting, Exclusive Interviews, Featured Stories, Medical 3D Printing |   Anthony Atala is a...

KENNEDY SPACE CENTER (FL), April 22, 2019 – The International Space Station (ISS) U.S. National Laboratory is finalizing more than a dozen payloads for launch to the orbiting laboratory aboard SpaceX’s Dragon spacecraft. Many of these payloads are aimed at improving...